1 |
Single and Systems Telecom, "The Pre-Filled Syringes Market: 2015-2030-Opportunity, Challenges, Strategies & Forecasts," Dubai, 2013.
|
2 |
Justin M. Wright, "Developing Containers and Devices to Meet Emerging and Evolving Parenteral Needs," ONdrugDelivery, United Kingdom, pp. 22-24, 2011.
|
3 |
O. Napoleon Monroe, N. Lawrence Dalling, Clarence M. Mesa, "Dispersion Multichamber Auto-injector," US Pat. No. 5,092,843 A, 1992.
|
4 |
H. P. Shin, W. J. Seo, S. J. Choi, B. I. Hur, K. W. Lee, T. K. Kwon, B. K. Im, "2-Chamber Syringe," KR Pat. No. 10-1508217, 2015.
|
5 |
H. P. Shin, W. J. Seo, S. J. Choi, B. I. Hur, K. W. Lee, T. K. Kwon, B. K. Im, "2-Chamber Syringe," KR Pat. No. 10-1508218, 2015.
|
6 |
"Trend Survey Report of Patent Technology," Korea Intellectual Property Strategy Agency, 2014.
|
7 |
"Coil Compression Springs for Auto-Injector Syringes," Acxess Spring. 2016.
|
8 |
KS B 2400, Helical Compression and Extension Springs-Requirement for Design.
|
9 |
Christin Selent-Stier, "Development of an Adequate Strategy for a Global Change in the Primary Container Closure System of a Parenteral Herbal Drug," Deutsche Gesellschaft for Regulatory Affairs, 2013.
|
10 |
Sagar Makwana, Biswajit Basu, Yogita Makasana,1 and Abhay Dharamsi, “Prefilled Syringes: An Innovation in Parenteral Packaging,” International Journal of Pharmaceutical Investigation, Vol. 1, No. 4, pp. 200-206, 2011.
DOI
|
11 |
Y. SHIRAISHI, Y. IKEGUCHI, "Corporate Profile & . ," Taisei Kako Co., Ltd. 2015.
|
12 |
TOPAS, Medical brochure, 2011.
|
13 |
Kathy Quan, RN, BSN, PHIN, "How to Determine Needle Size," Nursing Link, 2016.
|
14 |
"Adrenaline Auto-injectors: A Review of Clinical and Quality Considerations," Medicines and Healthcare Products Regulatory Agency, United Kingdom, 2014.
|
15 |
Jonathan Wilkins, Iain Simpson, "Mathematical Modelling for Faster Auto-Injector Design," Innovations in Pharmaceutical Technology, Issue 42, pp. 42-45, 2012.
|
16 |
"Guidance for Industry and FDA Staff: Technical Considerations for Pen, Jet, and Related Injectors Intended for Use with Drugs and Bioloigical Products," U.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health, 2013.
|
17 |
Atropine Injector, Automatic, Nerve Agent Antidote, KDS-6505-1002-3
|
18 |
Pralidoxime Chloride Injection, KDS-6505-1005-3.
|
19 |
Choi Dong-Won, Sohng Kyeong-Yae, Kim Bum-Soo, "Prediction of Optimal Gluteal Intramuscular Needle Length by Skinfold Thickness Measurements in Korean Adults," Journal of Korean Acad Nurs, Vol. 40, No. 6, pp. 844-851, 2010.
DOI
|